XSTEM-VLU / Xintela - LARVOL DELTA

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (clinicaltrials.gov) - P1/2 | N=6 | Recruiting | Sponsor: Xintela AB | N=12 ➔ 6 | Trial completion date: Jun 2025 ➔ Oct 2025 | Trial primary completion date: Jun 2025 ➔ Oct 2025

Enrollment change • Trial completion date • Trial primary completion date • Venous Ulcer

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (clinicaltrials.gov) - P1/2 | N=12 | Recruiting | Sponsor: Xintela AB | Trial completion date: Dec 2024 ➔ Jun 2025 | Trial primary completion date: Dec 2024 ➔ Jun 2025

Trial completion date • Trial primary completion date • Venous Ulcer

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (clinicaltrials.gov) - P1/2 | N=12 | Recruiting | Sponsor: Xintela AB | Trial completion date: Jun 2024 ➔ Dec 2024 | Trial primary completion date: Jun 2024 ➔ Dec 2024

Trial completion date • Trial primary completion date • Venous Ulcer

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (clinicaltrials.gov) - P1/2 | N=12 | Recruiting | Sponsor: Xintela AB

Trial completion date • Trial primary completion date • Venous Ulcer

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (clinicaltrials.gov) - P1/2 | N=12 | Recruiting | Sponsor: Xintela AB | Trial completion date: Jun 2023 ➔ Jun 2024 | Trial primary completion date: Jun 2023 ➔ Jun 2024

Trial completion date • Trial primary completion date • Venous Ulcer

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (clinicaltrials.gov) - P1/2 | N=12 | Recruiting | Sponsor: Xintela AB | Not yet recruiting ➔ Recruiting

Enrollment open • Venous Ulcer

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers (clinicaltrials.gov) - P1/2 | N=12 | Not yet recruiting | Sponsor: Xintela AB

New P1/2 trial • Venous Ulcer